Basel Medical Group Ltd (NASDAQ:BMGL – Get Free Report) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 159,585 shares, a growth of 1,917.0% from the August 31st total of 7,912 shares. Based on an average trading volume of 3,135,507 shares, the days-to-cover ratio is currently 0.1 days. Currently, 10.1% of the company’s shares are sold short.
Wall Street Analyst Weigh In
Separately, Weiss Ratings lowered shares of Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, September 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.
Check Out Our Latest Research Report on Basel Medical Group
Basel Medical Group Stock Down 7.1%
Basel Medical Group (NASDAQ:BMGL – Get Free Report) last posted its quarterly earnings results on Friday, June 26th. The company reported $0.01 EPS for the quarter. The business had revenue of $3.21 million during the quarter.
Basel Medical Group Company Profile
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.
See Also
- Five stocks we like better than Basel Medical Group
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
